KEGG icon

Drug interaction list


Query:
D01098  Maxacalcitol (JAN/USAN/INN); Oxarol (TN); Prezios (TN)

Interactions: 121 hits    [ ATC classification | Therapeutic category ]

C08130  Calcium chloride anhydrous (P) unclassified
D00122  Calcifediol (USP/INN); Calcifediol monohydrate; Calderol (TN); Rayaldee (TN) (P) Target: VDR
D00129  Calcitriol (JAN/USP/INN); Rocaltrol (TN) (P) Target: VDR
D00184  Cyclosporine (USP); Ciclosporin (JP17); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D00187  Ergocalciferol (JP17/USP); Vitamin D2; Calciferol (TN); Drisdol (TN) (P) Target: VDR
D00188  Cholecalciferol (JP17/USP); Colecalciferol (INN); Vitamin D3; Delta-D (TN) (P) Target: VDR
D00211  Rifampin (USP); Rifampicin (JP17/INN); Rifadin (TN); Rimactane (TN) (P) CYP induction: CYP3A4
D00276  Clarithromycin (JP17/USP/INN); CAM; Biaxin (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D00297  Digitoxin (JAN/USP/INN); Crystodigin (TN) (P) unclassified
D00298  Digoxin (JP17/USP); Lanoxicaps (TN); Lanoxin (TN) (P) unclassified
D00299  Dihydrotachysterol (JAN/USP/INN); Hytakerol (TN) (P) Target: VDR
D00420  Mitotane (JAN/USP/INN); Lysodren (TN) (P) unclassified
D00472  Prednisolone (JP17/USP/INN); Delta-cortef (TN) (P) unclassified
D00506  Phenobarbital (JP17/USP/INN); Luminal (TN) (P) unclassified
D00512  Phenytoin (JP17/USP/INN); Dilantin (TN) (P) unclassified
D00550  Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) (P) Enzyme: CYP3A4
D00628  Secalciferol (JAN/USAN/INN); Osteo D (TN) (P) Target: VDR
D00636  Amiodarone hydrochloride (JP17/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) (P) Enzyme: CYP3A4
D00701  Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) (P) unclassified
D00731  Magnesium hydroxide (JAN/USP); Magnesia, (Milk of) (USP); Milmag (TN); Mint-o-mag (TN) (P) unclassified
D00831  Mefloquine hydrochloride (JP17/USP); Lariam (TN) (P) unclassified
D00899  Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D00930  Paricalcitol (JAN/USP/INN); Zemplar (TN) (P) Target: VDR
D00931  Calcium acetate (USP); Phoslo (TN) (P) unclassified
D00932  Calcium carbonate (USP); Precipitated calcium carbonate (JP17); Calcium carbonate, precipitated (JAN); Cal-sup (TN) (P) unclassified
D00933  Calcium citrate (USP); Calcium citrate tetrahydrate; Citracal (TN) (P) unclassified
D00934  Calcium gluceptate (USP); Calcium glucoheptonate (INN); Calcium gluceptate (TN) (P) unclassified
D00935  Calcium gluconate (USP) (P) unclassified
D00936  Calcium lactate (USP); Prequist powder (TN) (P) unclassified
D00937  Calcium phosphate, dihydrate, dibasic (USP); Dibasic calcium phosphate hydrate (JP17); Dibasic calcium phosphate (TN); Calster (TN) (P) unclassified
D00938  Tricalcium phosphate; Posture (TN) (P) unclassified
D00961  Bicalutamide (JAN/USP/INN); Casodex (TN) (P) unclassified
D00981  Prednisolone sodium phosphate (JP17/USP); Pediapred (TN) (P) unclassified
D01009  Doxercalciferol (USAN/INN); Hectorol (TN) (P) Target: VDR
D01098  Maxacalcitol (JAN/USAN/INN); Oxarol (TN); Prezios (TN) (P) Enzyme: CYP3A4 / Target: VDR
D01125  Calcipotriene (USP); Calcipotriol (JAN); Dovonex (TN) (P) Target: VDR
D01167  Magnesium oxide (JP17/USP); Magmitt (TN) (P) unclassified
D01239  Prednisolone sodium succinate (JP17/USP); Kohakusanin (TN) (P) unclassified
D01240  Deslanoside (JP17/USP/INN); Cedilanid-d (TN) (P) unclassified
D01253  Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) (P) Enzyme: CYP3A4
D01276  Atazanavir sulfate (JAN/USAN); Reyataz (TN) (P) unclassified
D01472  Tacalcitol hydrate (JP17); Bonalfa high (TN); Curatoderm (TN) (P) Target: VDR
D01518  Alfacalcidol (JAN/INN); Alsiodol (TN) (P) Target: VDR
D01598  Calcium L-aspartate hydrate (JAN); Calcium L-aspartate; Aspara-CA (TN) (P) unclassified
D01662  Falecalcitriol (JAN/INN); Hornel (TN) (P) Target: VDR
D01855  Mozavaptane hydrochloride (JAN) (P) Enzyme: CYP3A4
D01972  Lanatoside C (JAN/INN); Digilanogen C (TN) (P) unclassified
D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP17); Aleviatin (TN); Dilantin (TN) (P) unclassified
D02254  Calcium lactate hydrate (JP17); Calcium lactate pentahydrate; Calcium lactate (TN) (P) unclassified
D02256  Calcium chloride (USP); Calcium chloride hydrate (JP17); Calcium chloride dihydrate; Conclyte-Ca (TN) (P) unclassified
D02372  Perospirone hydrochloride hydrate (JAN); Lullan (TN) (P) unclassified
D02484  Artemether and lumefantrine; Coartem (TN) (P) unclassified
D02587  Metildigoxin (JP17); Lanirapid (TN) (P) unclassified
D02691  Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Nutropin (TN); Omnitrope (TN) (P) unclassified
D02732  Pranlukast hydrate (JP17); Onon (TN) (P) Enzyme: CYP3A4
D02763  Actodigin (USAN/INN) (P) unclassified
D02867  Fosamprenavir calcium hydrate (JAN); Lexiva (TN) (CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D02968  Aprepitant (JAN/USP/INN); Emend (TN); Cinvanti (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4
D03106  Bexarotene (JAN/USAN/INN); Targretin (TN) (P) unclassified
D03294  Calcium glubionate (USP/INN); Neo-calglucon (TN) (P) unclassified
D03302  Dibasic calcium phosphate, anhydrous (JAN); Calcium phosphate, dibasic; CalStar (TN) (P) unclassified
D03303  Calcium phosphate, tribasic (NF) (P) unclassified
D03306  Calcium polycarbophil (USP); Polycarbophil calcium (JAN); Mitrolan (TN) (P) unclassified
D03309  Calcium silicate (NF) (P) unclassified
D03358  Teriparatide acetate (JAN); Human PHT (TN) (P) unclassified
D03669  Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) (P) CYP induction: CYP3A4
D03819  Digitalis (USP); Digiglusin (TN) (P) unclassified
D03930  Ecalcidene (USAN/INN) (P) Target: VDR
D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) (P) Enzyme: CYP3A4
D04059  Mepenzolate bromide and phenobarbital; Trancolon P (TN) (P) unclassified
D04307  Proxyphylline, ephedrine hydrochloride and phenobarbital; Asthmolysin D (TN) (P) unclassified
D04393  Aluminum hydroxide and magnesium hydroxide; Aluminum hydroxide and magnesium hydroxide; Maalox (TN); Sakloft (TN) (P) unclassified
D04641  Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D04666  Lanreotide acetate (JAN/USAN); Somatuline (TN) (P) unclassified
D04952  Potassium aspartate and magnesium aspartate (JAN/USAN); Aspara (TN) (P) unclassified
D05364  Parathyroid hormone (human) (USAN); Parathyroid hormone (INN); ALX 1-11; Parathormone; PTH; Natpara (TN) (P) unclassified
D05463  Calcium gluconate hydrate (JP17); Calcicol (TN) (P) unclassified
D05775  Rufinamide (JAN/USP/INN); Banzel (TN) (P) unclassified
D05821  Semparatide acetate (USAN); Semparatide acetate hydrate (P) unclassified
D06078  Teriparatide (USP/INN); Teriparatide (genetical recombination) (JAN); Teriparatide (genetical recombination) [Teriparatide biosimilar 1] (JAN); Forteo (TN) (P) unclassified
D06413  Nilotinib hydrochloride hydrate (JAN); Tasigna (TN) (P) Enzyme: CYP3A4
D06414  Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) (P) Enzyme: CYP3A4
D06437  Anhydrous dibasic calcium phosphate (JP17) (P) unclassified
D06546  Teriparatide acetate (USAN); Teriparatide acetate hydrate; Parathar (TN) (P) unclassified
D06597  Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4
D06881  Acetyldigitoxin (INN); Acylanid (TN) (P) unclassified
D07147  Gitoformate (INN) (P) unclassified
D07555  Acetyldigoxin; Cedigossima (TN) (P) unclassified
D07556  beta-Acetyldigoxin; Acetyldigoxin beta isomer; Corotal (TN) (P) unclassified
D07578  Eldecalcitol (JAN/INN); Edirol (TN) (P) Target: VDR
D07583  Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) (P) unclassified
D07595  Fosphenytoin sodium hydrate (JAN); Fostoin (TN) (P) CYP induction: CYP3A4
D08554  Tacalcitol (INN); Bonalfa (TN) (P) Target: VDR
D08704  Magnesium aluminometasilicate, methylmethionine sulfonium chloride, magnesium carbonate and precipitated calcium carbonate; Cabagin-U (TN) (P) unclassified
D08708  Licase (alpha Amylase), aluminum hydroxide, dried, magnesium carbonate, sodium bicarbonate and precipitated calcium carbonate; AM (TN); NS (TN) (P) unclassified
D08834  Stomachic and digestive; Ohara (TN) (P) unclassified
D08868  Becocalcidiol (USAN/INN) (P) Target: VDR
D09019  Tisocalcitate (INN/USAN) (P) unclassified
D09197  Valsartan and hydrochlorothiazide (JP17); Co-dio (TN) (P) unclassified
D09638  Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) (P) Enzyme: CYP3A4
D09731  Crizotinib (JAN/USAN/INN); Xalkori (TN) (P) Enzyme: CYP3A4
D09847  Metildigoxin (INN); Medigoxin (BAN) (P) unclassified
D09928  Lunacalcipol (USAN/INN) (P) unclassified
D09996  Vemurafenib (JAN/USAN/INN); Zelboraf (TN) (P) unclassified
D10003  Hemin (JAN); Normosang (TN) (P) unclassified
D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) (P) Enzyme: CYP3A4 / CYP induction: CYP3A4
D10161  Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) (P) unclassified
D10198  Calcipotriol hydrate (JAN); Calcipotriol monohydrate; Calcipotriene hydrate; Dovonex (TN) (P) Target: VDR
D10218  Enzalutamide (JAN/USAN); Xtandi (TN) (P) unclassified
D10372  Palbociclib (JAN/USAN); Ibrance (TN) (P) unclassified
D10534  Calcipotriene and betamethasone dipropionate; Calcipotriol and betamethasone dipropionate; Dovobet (TN); Enstilar (TN); Taclonex (TN) (P) unclassified
D10551  Ceritinib (JAN/USAN/INN); Zykadia (TN) (P) unclassified
D10564  Amenamevir (JAN/INN); Amenalief (TN) (P) unclassified
D10566  Pasireotide pamoate (JAN); Signifor lar (TN) (P) unclassified
D10762  Fosravuconazole L-lysine ethanolate (JAN) (P) unclassified
D10788  Maxacalcitol and betamethasone butyrate propionate; Marduox (TN) (P) same components
D10801  Letermovir (JAN/USAN/INN); Prevymis (TN) (P) unclassified
D10913  Burosumab (USAN/INN); Burosumab (genetical recombination) (JAN); Burosumab-twza; Crysvita (TN) (P) unclassified
D10926  Entrectinib (JAN/USAN/INN); Rozlytrek (TN) (P) Enzyme: CYP3A4
D11012  Lorlatinib (JAN/USAN/INN); Lorbrena (TN) (P) unclassified
D11040  Apalutamide (JAN/INN); Erleada (TN) (P) Enzyme: CYP3A4 / CYP induction: CYP3A4